MedRx Co., Ltd (TYO:4586)

Japan · Delayed Price · Currency is JPY

67.00

+1.00 (1.52%)

Aug 27, 2026, 3:30 PM JST

MedRx Financials Overview

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	121	128	257	29	59	8
Revenue Growth	175.00%	-50.20%	786.21%	-50.85%	637.50%	-93.04%
Gross Profit	118	126	257	26	56	6
Operating Income	-876	-942	-793	-934	-1,101	-1,061
Net Income	-859	-937	-806	-932	-1,111	-1,059
Earnings Per Share	-14.58	-17.44	-18.54	-26.80	-43.80	-49.58
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Japan	103.98	0.33	29	59	8
United States of America	24.11	257.59	-	-	-
Total	128.08	257.91	29	59	8

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,143	1,754	1,977	1,720	994	1,703
Total Debt	-	-	-	-	-	-
Net Cash (Debt)	1,143	1,754	1,977	1,720	994	1,703
Net Cash Growth	-31.43%	-11.28%	14.94%	73.04%	-41.63%	-3.35%
Net Cash Per Share	19.40	32.64	45.48	49.46	39.19	79.74

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-895	-888	-803	-913	-1,073	-923
Capital Expenditures	-85	-82	-	-	-1	-2
Free Cash Flow	-980	-970	-803	-913	-1,074	-925
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	97.52%	98.44%	100.00%	89.66%	94.92%	75.00%
Operating Margin	-723.97%	-735.94%	-308.56%	-3220.69%	-1866.10%	-13262.50%
Pretax Margin	-699.17%	-722.66%	-312.06%	-3206.90%	-1881.36%	-13225.00%
Profit Margin	-709.92%	-732.03%	-313.62%	-3213.79%	-1883.05%	-13237.50%
FCF Margin	-809.92%	-757.81%	-312.45%	-3148.28%	-1820.34%	-11562.50%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	8.82	8.82	8.82	8.82	8.82
PS Ratio	32.88	50.09	15.11	199.76	45.17	393.52